Tuberc Respir Dis.  2007 Apr;62(4):263-269. 10.4046/trd.2007.62.4.263.

Autofluorescence Bronchoscopy

• Jang TW

• KMID: 1970225
• DOI: http://doi.org/10.4046/trd.2007.62.4.263

Abstract

No abstract available.

MeSH Terms

Bronchoscopy*

Figure

• 

  Figure 1 Spectrum of normal and preinvasive lesion.

• 

  Figure 2 Progressive loss of autofluorescence with submucosal diseases (primarily green to red/brown appearance).

• 

  Figure 3 Lung field cancerization & multistep tumorigenesis.

Reference

1. Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, et al. Cancer incidence in Korea. Cancer Res Treat. 2002. 34:405–408.

2. Weir HK, Thun MJ, Hankey BF, Ries LAG, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003. 95:1276–1299.

3. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer. 1974. 33:256–270.

4. Anderson GH, Boyes DA, Benedet JL, Le Riche JC, Matisic JP, Suen KC, et al. Organization and results of the cervical cytology screening programme in British Columbia, 1955-1985. Br Med J. 1988. 296:975–978.

5. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. for The National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med. 1993. 328:901–906.

6. Thunnissen FB. Sputum examination for early detection of lung cancer. J Clin Pathol. 2003. 5:805–810.

7. Bunn PJ Jr. Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation? J Clin Oncol. 2003. 21:3891–3893.

8. Cortese DA, Pairolero PC, Bergstralh EJ, Wooler LB, Uhlenhopp MA, Piehler JM, et al. Roentgenographically occult lung cancer: a ten-year experience. J Thorac Cardiovasc Surg. 1983. 86:373–380.

9. Lam S, Mac Auley C, Le Riche JC, Ikeda N, Palcic B. Early localization of bronchogenic carcinoma. Diagn Ther Endosc. 1994. 1:75–78.

10. Nasiell M. Metaplasia and atypical metaplasia in the bronchial epithelium: a histopathologic study. Acta Cytol. 1966. 10:421–424.

11. Hayata Y, Kato H, Ono J, Matsushima Y, Hayashi N, Saito T, et al. Fluorescence fiberoptic bronchoscopy in the diagnosis of early stage lung cancer. Recent Results Cancer Res. 1982. 82:121–130.

12. Herth FJF, Ernst A, Becker HD. Autofluorescence bronchoscopy: a comparison of two systems (LIFE and D-Light). Respiration. 2003. 70:395–398.

13. Lee SH, Shim JJ, Lee SR, Lee SY, Suh JK, Cho JY, et al. Useful of LIFE in diagnosis of bronchogenic cancer. Tuberc Respir Dis. 1996. 44:70–84.

14. Jang TW, Oak CH, Chun BK, Jung MH. Detection of pre-invasive endobronchial umors with D-light/Autofluorescence system. J Korean Med Sci. 2006. 21:242–246.

15. Kwon SJ, Lee YS, Jung MK, Lee YJ, Jang PS, Lee JE, et al. Primary synchronous lung cancer detected using autofluorescence bronchoscopy. Tuberc Respir Dis. 2006. 60:646–652.

16. Chiyo M, Shibuya K, Hoshino H, Yasufuku K, Sekine Y, Lizasa T, et al. Effective detection of bronchial preinvasive lesions by a new autofluorescence imaging bronchovideoscope system. Lung Cancer. 2005. 48:307–313.

17. Ikeda N, Honda H, Hayashi A, Usuda J, Kato Y, Tsuboi M, et al. Early detection of bronchial lesions using newly developed videoendoscopy-based autofluorescence bronchoscopy. Lung Cancer. 2006. 52:21–27.

18. Lam S, MacAulay C, Hung J, LeRiche J, Profio AE, Palcic B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg. 1993. 105:1035–1040.

19. Lam S, Hung JY, Kenney SM, LeRiche JC, Vedal S, Nelems B, et al. Detection of dysplasia and caicinoma in situ by ratio fluorometry. Am Rev Respir Dis. 1992. 146:1458–1461.

20. Keith RL, Miller YE, Gemmill RM, Drabkin HA, Dempsey EC, Kennedy TC, et al. Angiogenic squamous dysplasia in bronchi of individual at high risk for lung cancer. Clin Cancer Res. 2000. 6:1616–1625.

21. Hirsch FR, Prindiville SA, Miller YE, Franklin WA, Dempsey EC, Murphy JR, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst. 2001. 93:1385–1391.

22. Woolner LB, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc. 1984. 59:453–466.

23. Sato M, Sakurada A, Sagawa M, Minowa M, Takahashi H, Oyaizu T, et al. Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening. Lung Cancer. 2001. 32:247–253.

24. Lam S, MacAulay JC, LeRiche JC, Palcic B. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer. 2000. 89:2468–2473.

25. Venmans BJW, van Boxem TJM, Smit EF, Postmus PE, Sutedja TG. Outcome of bronchial carcinoma in situ. Chest. 2000. 117:1572–1576.

26. Bota SJ, Auliac C, Paris J, Metayer R, Sesboue G, Nouvet . Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med. 2001. 164:1688–1693.

27. Häußinger K, Becker H, Stanzel F, Kreuzer A, Schmidt B, Strausz J, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax. 2005. 60:496–503.

28. O'Neil KM, Johnson BE. Lights flicker on fluorescence bronchoscopy in patients at risk for lung cancer. J Natl Cancer Inst. 1998. 90:2468–2473.

29. Kenndy TC, Lam S, Hirsch FR. Review of recent advances in fluorescence bronchoscopy in early localization of central airway lung cancer. Oncologist. 2001. 6:257–262.

30. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997. 89:1366–1373.

31. Kurie JM, Lee JS, Morice RC, Walsh GL, Khuri FR, Broxon A, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst. 1998. 90:991–995.

32. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998. 90:1335–1345.

33. Wigel TLS, Yousem S, Dacic S, Kosco PJ, Siegfried J, Luketich JD. Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer. Ann Surg Oncol. 2000. 7:176–180.

34. Wigel TLS, Kosco PJ, Dacic S, Rusch VW, Ginsberg RJ, Luketich JD. Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. Ann Thorac Surg. 2001. 71:967–970.

35. Venmans BJ, van Boxem TJM, Smit EF, Postmus PE, Sutedja TG. Bronchial intraepithelial neoplastic lesions in head and neck cancer patients: results of autofluorescence bronchoscopy. Ann Otol Rhinol Laryngol. 2001. 110:635–638.

36. Sutedja TG, Codrington H, Risse EK, Breuer RH, van Mourik JC, Golding RP, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest. 2001. 120:1327–1332.